Villanova Investment Management Co LLC Has $1.33 Million Holdings in Phibro Animal Health Corporation $PAHC

Villanova Investment Management Co LLC decreased its holdings in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 63.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,829 shares of the company’s stock after selling 58,029 shares during the quarter. Villanova Investment Management Co LLC owned 0.08% of Phibro Animal Health worth $1,328,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in PAHC. EverSource Wealth Advisors LLC increased its position in Phibro Animal Health by 7,671.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock worth $69,000 after purchasing an additional 2,685 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in shares of Phibro Animal Health by 768.2% during the second quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company’s stock worth $118,000 after buying an additional 4,079 shares during the last quarter. State of Wyoming increased its holdings in shares of Phibro Animal Health by 148.8% during the second quarter. State of Wyoming now owns 6,608 shares of the company’s stock worth $169,000 after buying an additional 3,952 shares in the last quarter. Cornerstone Investment Partners LLC bought a new position in shares of Phibro Animal Health in the 3rd quarter valued at $209,000. Finally, Balboa Wealth Partners bought a new position in shares of Phibro Animal Health in the 3rd quarter valued at $216,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PAHC has been the subject of a number of recent research reports. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday, December 29th. Morgan Stanley set a $49.00 price target on Phibro Animal Health in a report on Friday, February 6th. Zacks Research downgraded Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 9th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a report on Friday, November 7th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus price target of $37.50.

Phibro Animal Health Trading Up 1.8%

Shares of PAHC stock opened at $52.80 on Monday. The stock has a market cap of $2.14 billion, a price-to-earnings ratio of 23.47, a PEG ratio of 0.81 and a beta of 0.80. The stock has a 50-day moving average of $42.44 and a 200-day moving average of $40.14. The company has a current ratio of 3.05, a quick ratio of 1.22 and a debt-to-equity ratio of 2.14. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $56.30.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.18. The company had revenue of $373.91 million for the quarter, compared to analyst estimates of $355.64 million. Phibro Animal Health had a return on equity of 38.28% and a net margin of 6.29%.Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. On average, equities research analysts forecast that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Wednesday, March 4th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, March 4th. Phibro Animal Health’s dividend payout ratio is currently 21.33%.

Insider Buying and Selling at Phibro Animal Health

In related news, CEO Jack Bendheim sold 7,040 shares of Phibro Animal Health stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $51.40, for a total transaction of $361,856.00. Following the completion of the transaction, the chief executive officer owned 36,680 shares of the company’s stock, valued at $1,885,352. This trade represents a 16.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 293,920 shares of company stock worth $13,833,025 in the last ninety days. Corporate insiders own 50.13% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.